Source: WRAL TechWire

Cempra: Melinta, Cempra name new CEO of combined company

Melinta Theapeutics Inc. and Cempra Inc. have named verteran pharmaceutical executive Dan Wechsler president, CEO and board member of the combined company.

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
250-500
David Zaccardelli's photo - Interim-CEO of Cempra

Interim-CEO

David Zaccardelli

CEO Approval Rating

72/100

Read more